Oncology & Cancer

Patient-reported outcomes predict aromatase inhibitor adherence

If you want to predict which breast cancer patients will most likely stop taking aromatase inhibitors, check out their own responses to the health questions patients commonly answer in cancer clinical trials, according to ...

Psychology & Psychiatry

How do you know when it's time to break up? Here's the research

Christmas may be a time of giving, but it's also a peak time for break-ups. Facing the prospect of spending yet another festive season with their romantic partner, many people start having doubts about their relationship ...

Health

Without metrics, how do you rate drug treatment facilities?

Almost 10 percent of the nation's entire population live with substance use disorder, but many struggle to find the right help—a task which is made more difficult because there is no standardized rating system to ensure ...

Obstetrics & gynaecology

Guidebooks or grandmas? Where most moms get their pregnancy advice

As bookstores and libraries continue to line their shelves with self-help literature, most month-by-month pregnancy guides have one thing in common—recommendations to follow medical guidance over mom's advice, often arguing ...

HIV & AIDS

Communities key to fighting HIV, says UNAIDS report

The UN's AIDS organisation on Tuesday hailed an increase in the numbers of HIV-positive people getting treatment, and credited community-based programmes as the key to fighting the disease.

Oncology & Cancer

Endocrine therapy lowers QOL for breast cancer patients

(HealthDay)—Endocrine therapy reduces the quality of life of breast cancer patients, especially for postmenopausal women, according to a study recently published in the Annals of Oncology.

page 1 from 23